SHOCKWAVE: TRANSFORMING CARDIOVASCULAR DISEASE TRE
Post# of 1
$SWAV
Excited to share an article about Shockwave Medical, Inc. (NASDAQ: SWAV), a leading organization that develops and markets innovative technologies for the treatment of cardiovascular diseases.
The Company caters to various segments that have a combined market of over $9.5 billion. Shockwave Medical has consistently grown its revenues from $1.7 million in FY17 to $730.2 million in FY23, which represents a compound annual growth rate (CAGR) of 174%. Over the same period, the number of patients treated with its proprietary technology has increased from about 1,000 to 182,000. The quick acceptance of Shockwave's products in the market and the growing revenues show great potential for the Company, making it an interesting watch.
Read on to know more:
https://www.aviseanalytics.com/shockwave-tran...treatment/